Wordt geladen...
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria
Congenital erythropoietic porphyria (CEP), also known as Günther’s disease, results from a deficient activity in the fourth enzyme, uroporphyrinogen III synthase (UROIIIS), of the heme pathway. Ciclopirox (CPX) is an off-label drug, topically prescribed as an antifungal. It has been recently shown t...
Bewaard in:
| Gepubliceerd in: | J Pers Med |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8230281/ https://ncbi.nlm.nih.gov/pubmed/34071291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060485 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|